IL6 and lymphoma: Alternatively, higher concentrations of inflammatory and endothelial dysfunction markers among lymphoma patients including interleukin 6 are significantly correlated with decreased AMH concentrations [35] as well as CVD risk [36], suggesting that AMH may also be linked with CVD through this pathway.